Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boehringer-Ingelheim establishes D.C. presence

Executive Summary

Former American Hospital Association VP-Legislative Affairs Kirsten Morris and former Generic Pharmaceutical Association VP-Government Affairs Buddy Menn are establishing a Washington, D.C. office for Boehringer-Ingelheim. Menn was most recently chief-of-staff to Sen. Robert Graham (R-Fla.), and previously worked in government affairs for the National Association of Chain Drug Stores (1"The Pink Sheet" March 19, 2001, p. 7). The office opened in January. BI has a rapidly growing presence in the U.S. pharma market; its product line includes brands (Spiriva, Mobic, Aggrenox, Flomax, etc.), generics (Roxane labs), OTCs (Ducolax) and animal health...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel